Inflammatory bowel disease: perioperative pharmacological considerations. - Wikidata - awgldk - TriplyDB

Inflammatory bowel disease: perioperative pharmacological considerations.

Inflammatory bowel disease: perioperative pharmacological considerations.

http://www.wikidata.org/entity/Q30502980

about

Inflammatory bowel disease and thromboembolism Renal and Gastrointestinal Considerations in Joint Replacement Surgery.Perioperative Considerations in Crohn Disease and Ulcerative Colitis.Biologic therapy and surgery for crohn disease.[Multimodal oncological therapy concepts, chemotherapy and immunosuppressive drugs: effects on surgical morbidity and mortality].Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review.[Perioperative handling of immunosuppressive therapy].Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.The impact of Hispanic ethnicity and race on post-surgical complications in patients with inflammatory bowel disease.A risk score model of 30-day readmission in ulcerative colitis after colectomy or proctectomy

P2860

Q34326640-2361AE60-1890-4782-8465-1FDD01356F5B Q35207986-22A7BA6A-4CA3-4CDC-A5A3-8FBF90AEB615 Q36940448-97B33E5C-C6EB-4D30-8342-FE82A6D170F2 Q38179381-CD211046-303D-4900-B8D5-6DE9E971BDD7 Q44650345-3AD69229-E645-4B44-99BB-556070349D62 Q47886912-CA89EBDB-8A70-4FBD-A48C-5FF73B477251 Q49630842-D29B7740-EE5E-4C9A-86D1-84FF8DF0F518 Q53776698-33C3232D-81E5-4402-AE48-ED80388244B8 Q54080713-571E2E56-6297-4F0D-996C-2901E67C9CF3 Q58779103-772CFDA6-1B1E-4008-9122-CE53C22B7ED8

P2860

Inflammatory bowel disease: perioperative pharmacological considerations.

http://www.wikidata.org/entity/Q30502980

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inflammatory bowel disease: perioperative pharmacological considerations.

@ast

Inflammatory bowel disease: perioperative pharmacological considerations.

@en

type

label

Inflammatory bowel disease: perioperative pharmacological considerations.

@ast

Inflammatory bowel disease: perioperative pharmacological considerations.

@en

prefLabel

Inflammatory bowel disease: perioperative pharmacological considerations.

@ast

Inflammatory bowel disease: perioperative pharmacological considerations.

@en

P1433

Q30502980-3A226F87-A8BE-47EC-B507-6B89C0D9CE1E

P1476

Q30502980-CCB0150C-0961-473F-B559-300329BD7C2B

P2093

Q30502980-19EBD8CF-10A1-4172-A2E1-DD8016586F3F

Q30502980-484C5797-B0A0-4963-B7D3-1791AD79C7D9

Q30502980-669DC6D4-6623-4F45-B051-9DF024985CB4

Q30502980-C082F1E5-5D0A-4BEA-9EE4-0A8ADB0A8920

Q30502980-DCC89C69-1C34-4DA6-9FC3-0E1995CCC843

Q30502980-FD81DD75-007C-49BA-BBEE-C0EAC46C4D42

P2860

Q30502980-095EB641-C20C-4997-92B4-3D1D87849B67

Q30502980-0E6A07E7-CC3D-4D0B-838D-6BD9220378B0

Q30502980-17D745AA-E0DD-4835-AF75-59195B3785BB

Q30502980-189832AB-158A-42FB-A1C0-4D2F502FE722

Q30502980-2113685F-CB33-4EF1-9668-07E441DE8793

Q30502980-21661250-F947-47B8-97B8-A6F6579FF3BB

Q30502980-22716C86-70A4-44A1-B592-C8A9AF3860CD

Q30502980-227F8DF6-2AB3-4D17-A1C0-2BCFF01832C3

Q30502980-27CC2990-D2D1-414E-956E-6D7BBE410B4D

Q30502980-2968EB3F-ECCB-4494-9CCB-64E7D73FEE56

P304

Q30502980-2B41E034-0C72-449F-88FE-EF29E4C61F4E

P31

Q30502980-A4563D97-ED81-4C93-BF8A-772954DA0ED6

P356

Q30502980-5375738D-3DFD-46F2-975E-FDD9EAA77785

P407

Q30502980-67924781-6A6E-4D89-8441-892A1F4C0380

P433

Q30502980-FE825538-9460-45E7-93A4-E5BF5237A167

P478

Q30502980-1E06A552-2E9D-4339-BA82-C1C844794DD3

P577

Q30502980-BB29978F-0745-4262-A7EE-B3BC600C6E72

P5875

Q30502980-30680062-B945-4411-B3C2-52F4969BE022

P698

Q30502980-6F853E5B-C28F-4D0F-A985-D3A1DC047078

P921

Q30502980-059A5FB7-1405-4B84-8E2C-78A796DBE23F

Q30502980-D507DF78-6C70-43FB-ADC3-0E5B3FDA618F

P932

Q30502980-92194FF9-7E3C-4ACF-94E8-89010C582318

P356

P1433

Mayo Clinic Proceedings

P1476

Inflammatory bowel disease: perioperative pharmacological considerations.

@en

P2093

Ajay Kumar

http://www.w3.org/2001/XMLSchema#string

Alok Jain

http://www.w3.org/2001/XMLSchema#string

Ashish Aneja

http://www.w3.org/2001/XMLSchema#string

Bo Shen

http://www.w3.org/2001/XMLSchema#string

Franziska Mohr

http://www.w3.org/2001/XMLSchema#string

Moises Auron

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory bowel disease: clinical aspects and established and evolving therapies

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Certolizumab pegol for the treatment of Crohn's disease

Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery

A systematic review on the optimum management of the use of methotrexate in rheumatoid arthritis patients in the perioperative period to minimize perioperative morbidity and maintain disease control.

The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

P304

748-757

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4065/MCP.2011.0074

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51535224

http://www.w3.org/2001/XMLSchema#string

P698

21803957

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

3146375

http://www.w3.org/2001/XMLSchema#string